Global herd immunity remains out of reach because of inequitable vaccine distribution – 99% of people in poor countries are unvaccinated

The high costs of the world's colossally unequal COVID-19 immunization rates.

Maria De Jesus, Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service • conversation
June 22, 2021 • ~9 min

Ending the pandemic will take global access to COVID-19 treatment and vaccines – which means putting ethics before profits

The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.

Nicole Hassoun, Associate Professor of Philosophy, Binghamton University, State University of New York • conversation
July 16, 2020 • ~9 min

/

1